- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
September 20th, 2007
SNM seeks novel approaches to molecular imaging to showcase at annual meeting
Attention scientific researchers: SNM invites you to present your molecular imaging studies -- especially those involving non-radioactive molecular imaging techniques and agents -- at the society's 55th Annual Meeting June 14-18, 2008, in New Orleans, La. SNM, the world's largest society for molecular imaging and nuclear medicine professionals, will showcase these studies in a new scientific investigation track called "Novel Approaches to Molecular Imaging."
"The emerging field of molecular imaging is a multidisciplinary endeavor that draws researchers from fields as diverse as biochemistry, organic chemistry, genetics, bioengineering, optics, medical imaging, medical physics, nuclear medicine and radiation oncology," said SNM President Alexander J. McEwan, who represents more than 16,000 molecular imaging and nuclear medicine professionals. "SNM -- with its mission to improve health care by advancing molecular imaging and therapy -- wants to spotlight today's work with imaging agents including contrast agents, nanoparticles, fluorescent dyes and proteins, microbubbles and techniques such as magnetic resonance, spectroscopy, ultrasound, multi-slice computed tomography and optical imaging of bioluminescence and fluorescence," added McEwan, professor and chair of the Department of Oncology, Faculty of Medicine, at the University of Alberta, and director of oncologic imaging at Cross Cancer Institute in Edmonton, Canada.
|Related News Press|
Scientists found a natural nanostructure to control the flow of light October 4th, 2015
Production of High Temperature Ceramics with Modified Properties in Iran October 2nd, 2015
ISO Approves 2 Int'l Nanotechnology-Related Standards Proposed by Iran October 2nd, 2015
Physicists map the strain, pixel by pixel, in wonder material graphene September 30th, 2015
Arrowhead Nominates ARC-HIF2 As First RNAi Therapeutic Candidate Using Extrahepatic DPC(TM) Delivery System: Data to be presented September 27 at the European Cancer Conference 2015 in Vienna September 11th, 2015